Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Skin Tumor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Very early researchEnrolling By InvitationNCT07023848
What this trial is testing

PET Image Exploration of 89Zr-labeled Antibody Fragments Targeting HER2 in Patients With Malignant Tumors

Who this might be right for
Breast CancerGastric Cancer (GC)Urothelial Carcinoma (UC)
Affiliated Hospital of Jiangnan University 10
Not applicableNot Yet RecruitingNCT06994078
What this trial is testing

Clinical Application of PET Imaging Targeting Nectin-4 in Malignant Tumors

Who this might be right for
Urothelial CarcinomaBreast CancerLung Carcinoma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 56
Not applicableUnknownNCT02891291
What this trial is testing

Optical Tomographic Scanner for Skin Lesions

Who this might be right for
Skin Cancer, Benign Skin Tumor, Inflammatory Skin Disease
National Taiwan University Hospital 300
Not applicableStudy completedNCT01509625
What this trial is testing

Retrospective Study Assessment Treatment Response Faslodex®( 500 mg)

Who this might be right for
Malignant Neoplasm of Breast Stage IV
Isabel Blancas 272
Not applicableStudy completedNCT01671943
What this trial is testing

Cryotherapy for Breast Cancer Trial

Who this might be right for
Breast Carcinoma
IceCure Medical Ltd. 4
Testing effectiveness (Phase 2)Study completedNCT03131908
What this trial is testing

Study of the Selective PI3K-Beta Inhibitor GSK2636771 in Combination With Pembrolizumab in Patients With Metastatic Melanoma and PTEN Loss

Who this might be right for
Melanoma and Other Malignant Neoplasms of SkinMetastatic Melanoma
M.D. Anderson Cancer Center 28
Testing effectiveness (Phase 2)Study completedNCT03541148
What this trial is testing

Evaluation of Oncoxin-Viusid® in Cutaneous Melanoma

Who this might be right for
Cutaneous Melanoma, Stage IIMalignant Cutaneous MelanomaCutaneous Melanoma, Stage III
Catalysis SL 20
Large-scale testing (Phase 3)Study completedNCT03551626
What this trial is testing

Study of Dabrafenib+Trametinib in the Adjuvant Treatment of Stage III BRAF V600+ Melanoma After Complete Resection to Evaluate the Impact on Pyrexia Related Outcomes

Who this might be right for
Malignant Melanoma
Novartis Pharmaceuticals 552
Testing effectiveness (Phase 2)UnknownNCT04749485
What this trial is testing

HX008 for the Treatment of Patients With Malignant Melanoma

Who this might be right for
Melanoma
Taizhou Hanzhong biomedical co. LTD 119
Not applicableUnknownNCT00368615
What this trial is testing

Characterization of the Melanoma-Specific Immune Response

Who this might be right for
Melanoma
University of California, Davis 20
Not applicableStudy completedNCT01393821
What this trial is testing

Menadione Topical Lotion in Treating Skin Discomfort and Psychological Distress in Patients With Cancer Receiving Panitumumab, Erlotinib Hydrochloride, or Cetuximab

Who this might be right for
Dermatologic ComplicationsMalignant NeoplasmPain
Mayo Clinic 27
Testing effectiveness (Phase 2)UnknownNCT02617849
What this trial is testing

Pembrolizumab With Carboplatin/Paclitaxel in Patients With Metastatic Melanoma

Who this might be right for
Metastatic Malignant Melanoma
Wilson Miller 30
Testing effectiveness (Phase 2)Study completedNCT00024011
What this trial is testing

PS-341 in Treating Patients With Metastatic Malignant Melanoma

Who this might be right for
Recurrent MelanomaStage IV Melanoma
National Cancer Institute (NCI) 50
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06708455
What this trial is testing

Phase 2b of RAPA-201 Cell Therapy in Post-PD-(L)-1 Melanoma

Who this might be right for
Malignant Melanoma With MetastasisMalignant MelanomaMalignant Melanoma Stage IIIc+1 more
Rapa Therapeutics LLC 65
Testing effectiveness (Phase 2)Ended earlyNCT02709889
What this trial is testing

Rovalpituzumab Tesirine in Delta-Like Protein 3-Expressing Advanced Solid Tumors

Who this might be right for
Malignant MelanomaMedullary Thyroid CancerGlioblastoma+5 more
AbbVie 200
Testing effectiveness (Phase 2)Ended earlyNCT05388435
What this trial is testing

Safety, Tolerability, PK/PD & Preliminary Efficacy of SKL27969 in Advanced Solid Tumors Patients

Who this might be right for
Advanced Solid Tumor
SK Life Science, Inc. 15
Testing effectiveness (Phase 2)Study completedNCT02306850
What this trial is testing

Neoadjuvant Pembrolizumab for Unresectable Stage III and Unresectable Stage IV Melanoma

Who this might be right for
Unresectable Malignant NeoplasmMelanomaMetastatic Melanoma+2 more
St. Louis University 10
Testing effectiveness (Phase 2)UnknownNCT04593485
What this trial is testing

Anti-PD-1 Antibody in the Treatment of Patients With Malignant Melanoma of the Female Genital Tract

Who this might be right for
Malignant Melanoma
Fudan University 40
Early research (Phase 1)Study completedNCT01997190
What this trial is testing

Intrapleural AdV-tk Therapy in Patients With Malignant Pleural Effusion

Who this might be right for
Malignant Pleural EffusionLung CancerMesothelioma+2 more
Candel Therapeutics, Inc. 19
Not applicableStudy completedNCT01372917
What this trial is testing

Evaluating AlloMax in Immediate Expander-Based Breast Reconstruction Study

Who this might be right for
Malignant Neoplasm of the BreastAcquired Absence of the Breast
National Center for Plastic Surgery, Virginia 39
Next Page